3163 ( IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation) is active and exclusively for claims involving partial blindness/vision loss caused by GLP-1 use
[3] [21] Improvements were also observed in other cardiometabolic markers, including triglycerides, fasting glucose, and waist circumference all independently associated with cardiovascular risk
It was observed that the drugs also resulted in weight loss in patients taking them
This indicates that its proliferative and cytoprotective effects on the gut epithelium are mediated indirectly via paracrine signaling ( GLP-2 is recognized as a key intestinal growth factor capable of enhancing mucosal proliferation, improving nutrient absorption, and maintaining gut barrier integrity ( Dipeptidyl peptidase IV DPP-IV, also known as CD26, is a serine protease that degrades both GLP-1 and GLP-2
Questions to ask your doctor about tirzepatide for weight loss Here are some questions you may want to ask your healthcare provider when you meet with them to discuss taking tirzepatide for weight loss